Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  04/26/2005
 
Trade Name:  Gemzar
 
Generic Name or Proper Name (*):  gemcitabine
 
Indications Studied:  Refractory leukemia
 
Label Changes Summary:  Effectiveness in pediatric patients has not been demonstrated Phase 1 trial in pediatric patients with refractory leukemia demonstrated a maximum tolerated dose; however, no meaningful clinical activity observed in a Phase 2 trial of gemcitabine in 22 patients with relapsed acute lymphoblastic leukemia and 10 patients with acute myelogenous leukemia Toxicities observed were similar to those reported in adults
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Lilly
 
Pediatric Exclusivity Granted Date:  01/27/2005
 
NNPS:  FALSE'
 
Therapeutic Category:  Antineoplastic
 
-
-